We've found
954
archived clinical trials in
Fibromyalgia
We've found
954
archived clinical trials in
Fibromyalgia
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Study of TD-9855 to Treat Fibromyalgia
Updated: 12/31/1969
A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of TD-9855 in Patients With Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comprehensive vs. Assisted Management of Mood and Pain Symptoms
Updated: 12/31/1969
Comprehensive vs. Assisted Management of Mood and Pain Symptoms (CAMMPS) Trial
Status: Enrolling
Updated: 12/31/1969
Comprehensive vs. Assisted Management of Mood and Pain Symptoms
Updated: 12/31/1969
Comprehensive vs. Assisted Management of Mood and Pain Symptoms (CAMMPS) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pain Outcomes Comparing Yoga Versus Structured Exercise (POYSE) Trial
Updated: 12/31/1969
Pain Outcomes Comparing Yoga Versus Structured Exercise (POYSE) Trial
Status: Enrolling
Updated: 12/31/1969
Pain Outcomes Comparing Yoga Versus Structured Exercise (POYSE) Trial
Updated: 12/31/1969
Pain Outcomes Comparing Yoga Versus Structured Exercise (POYSE) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST)
Updated: 12/31/1969
Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation
Status: Enrolling
Updated: 12/31/1969
Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST)
Updated: 12/31/1969
Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST)
Updated: 12/31/1969
Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation
Status: Enrolling
Updated: 12/31/1969
Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST)
Updated: 12/31/1969
Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Fibromyalgia Integrative Training for Teens
Updated: 12/31/1969
Fibromyalgia Integrative Training for Teens
Status: Enrolling
Updated: 12/31/1969
Fibromyalgia Integrative Training for Teens
Updated: 12/31/1969
Fibromyalgia Integrative Training for Teens
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
CEFALY® Device in the Treatment of Patients With Fibromyalgia
Updated: 12/31/1969
A Single Center, Pilot, Open Trial of the CEFALY® Device in the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
CEFALY® Device in the Treatment of Patients With Fibromyalgia
Updated: 12/31/1969
A Single Center, Pilot, Open Trial of the CEFALY® Device in the Treatment of Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Suvorexant in Insomnia Co-morbid With Fibromyalgia
Updated: 12/31/1969
A Double-blind, Crossover, Study to Compare the Hypnotic, Daytime Sleepiness/Fatigue, and Pain Effects of Nighttime Administration of Suvorexant 20 mg Versus Placebo in Patients With Fibromyalgia and Comorbid Insomnia
Status: Enrolling
Updated: 12/31/1969
Suvorexant in Insomnia Co-morbid With Fibromyalgia
Updated: 12/31/1969
A Double-blind, Crossover, Study to Compare the Hypnotic, Daytime Sleepiness/Fatigue, and Pain Effects of Nighttime Administration of Suvorexant 20 mg Versus Placebo in Patients With Fibromyalgia and Comorbid Insomnia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Making Better Lives: Patient-Focused Care for Low Back Pain (LBP)
Updated: 12/31/1969
Patient-Centered Versus Imaging-Directed Care for Older Veterans With Chronic LBP
Status: Enrolling
Updated: 12/31/1969
Making Better Lives: Patient-Focused Care for Low Back Pain (LBP)
Updated: 12/31/1969
Patient-Centered Versus Imaging-Directed Care for Older Veterans With Chronic LBP
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Making Better Lives: Patient-Focused Care for Low Back Pain (LBP)
Updated: 12/31/1969
Patient-Centered Versus Imaging-Directed Care for Older Veterans With Chronic LBP
Status: Enrolling
Updated: 12/31/1969
Making Better Lives: Patient-Focused Care for Low Back Pain (LBP)
Updated: 12/31/1969
Patient-Centered Versus Imaging-Directed Care for Older Veterans With Chronic LBP
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Effects of CBT and tDCS on Fibromyalgia Patients
Updated: 12/31/1969
The Effects of Cognitive Behavioral Therapy (CBT) and Transcranial Direct Current Stimulation (tDCS) on Fibromyalgia Patients
Status: Enrolling
Updated: 12/31/1969
The Effects of CBT and tDCS on Fibromyalgia Patients
Updated: 12/31/1969
The Effects of Cognitive Behavioral Therapy (CBT) and Transcranial Direct Current Stimulation (tDCS) on Fibromyalgia Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Low-level Laser Therapy in Patients With Chronic Fibromyalgia
Updated: 12/31/1969
A Prospective, Randomized, Double-blind, Sham-controlled Study of the Low-level Phoenix Thera-lase 42 Watt Laser in Patients With Chronic Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Low-level Laser Therapy in Patients With Chronic Fibromyalgia
Updated: 12/31/1969
A Prospective, Randomized, Double-blind, Sham-controlled Study of the Low-level Phoenix Thera-lase 42 Watt Laser in Patients With Chronic Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Updated: 12/31/1969
A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials